We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.
WhiteLab Genomics leverages graph knowledge technology and machine learning to help customers discover and design new genomic therapies. Our proprietary platform provides in-silico simulations to optimize payloads and vectors, based on exhaustive datasets.
Our technology enables scientists to reduce the development time of biotherapies, making them more accessible and affordable. Some biotherapies can cost up to $1 million, but our solutions aim to lower these costs significantly.
By combining computer science and biology, WhiteLab Genomics helps customers develop genomic medicines faster and more efficiently, making revolutionary drugs more accessible to patients in need. Our specialized AI platform is designed for DNA and RNA therapies, providing precise and exhaustive answers to key scientific and technological questions.
AI platform accelerating therapies for rare & inflammatory diseases.
Combinations therapy by rational design
We use AI to design antibodies for intractable diseases
The dynamic single-cell analysis company
AI-Powered Clinical Decision Support
Make undruggable targets a thing of the past
The robotic cloud laboratory for the life sciences.
Discovering drugs that target the DNA regulome
AI Hypothesis Engine for Molecular Discovery
Teaching Generative AI the Language of Biology
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS